Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2016-09-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1016/j.ijrobp.2016.03.053PMID 27325480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.

  2016cited by this paper
• Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long‐term follow‐up of a large series

  2015cited by this paper
• The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

  2015cited by this paper
• Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: Implications of treatment duration and tumor volume

  2014cited by this paper
• Proton radiation therapy for head and neck cancer: a review of the clinical experience to date.

  2014cited by this paper
• High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.

  2014cited by this paper
• Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.

  2013cited by this paper
• Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer.

  2013cited by this paper
• Clinical Investigation : Central Nervous System Tumor Proton Therapy for Reirradiation of Progressive or Recurrent Chordoma

  2013cited by this paper
• Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.

  2013cited by this paper
• Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.

  2012cited by this paper
• A treatment planning comparison of passive-scattering and intensity-modulated proton therapy for typical tumor sites.

  2012cited by this paper
• Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents

  2011cited by this paper
• Proton therapy for head and neck cancer: Rationale, potential indications, practical considerations, and current clinical evidence

  2011cited by this paper
• Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation

  2011cited by this paper
• Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer.

  2011cited by this paper
• The evolving role of radiation therapy in the management of malignant melanoma.

  2011cited by this paper
• Efficacy and toxicity of reirradiation using intensity‐modulated radiotherapy for recurrent or second primary head and neck cancer

  2010cited by this paper
• Pattern of Failure after Helical Tomotherapy in Head and Neck Cancer

  2010cited by this paper
• IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

  2009cited by this paper
• The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets.

  2009cited by this paper
• Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

  2008cited by this paper
• Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.

  2007cited by this paper
• Salvage re-irradiation for recurrent head and neck cancer.

  2007cited by this paper
• Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.

  2007cited by this paper
• Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

  2006cited by this paper
• Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.

  2003cited by this paper
• The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.

  2001cited by this paper
• Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy--dose-volume histogram analysis.

  1999cited by this paper
• Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.

  1998cited by this paper
• Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.

  1993cited by this paper
• Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

  1992cited by this paper

• Proton therapy for primary and recurrent HPV-related oropharyngeal cancer.

  2025cites this paper
• Reirradiation for Locally Recurrent Head and Neck Cancer: State-of-the-Art and Future Directions.

  2025cites this paper
• Patient Selection and Outcomes in Reirradiation for Head and Neck Cancers: A Prospective Cohort Study.

  2025cites this paper
• Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy.

  2025cites this paper
• Proton beam therapy indications in the Kingdom of Saudi Arabia

  2025cites this paper
• Prospective clinical trial of upright image-guided proton therapy for locally recurrent head and neck and brain malignancies.

  2025cites this paper
• Letter to editor on "Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer".

  2024cites this paper
• Factors Associated With and Characteristics of Patients Receiving Proton Therapy at the End of Life

  2024cites this paper
• Neurological complications of modern radiotherapy for head and neck cancer.

  2024cites this paper
• Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.

  2024cites this paper
• Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance

  2024cites this paper
• Analytical calculation of proton beam Bragg curve inside heterogeneous media

  2024cites this paper
• Emerging Radiotherapy Technologies for Head and Neck Squamous Cell Carcinoma: Challenges and Opportunities in the Era of Immunotherapy

  2024cites this paper
• Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma.

  2024cites this paper
• Dosimetric evaluation of intensity modulated photon versus proton reirradiation of head and neck cancer.

  2024cites this paper
• Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity

  2023cites this paper
• Re-irradiation practice and ESTRO/EORTC consensus recommendations: 2023 ASTRO education panel.

  2023cites this paper
• Comment on "A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer".

  2023cites this paper
• Adjuvant Reirradiation With Proton Therapy in Head and Neck Squamous Cell Carcinoma

  2023influential citation
• A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer.

  2023cites this paper
• Comparing the Oncologic Outcomes of Proton Therapy and Intensity-Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.

  2023cites this paper
• Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach—part I: prognostic factors and indications to treatment

  2023cites this paper
• Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy.

  2023cites this paper
• Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy

  2023cites this paper
• An Overview of Head and Neck Tumor Reirradiation: What Has Been Achieved So Far?

  2023cites this paper
• Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure

  2023influential citation
• Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations

  2023cites this paper
• Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation

  2023influential citation
• Advances in Proton Therapy for the Management of Head and Neck Tumors.

  2023cites this paper
• Proton beam therapy in repeat irradiation of recurrent head and neck tumors: analysis of short-term results

  2023cites this paper
• Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes

  2022cites this paper
• European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.

  2022cites this paper
• Advances in Image-Guided Radiotherapy in the Treatment of Oral Cavity Cancer

  2022cites this paper
• Current perspectives on recurrent HPV-mediated oropharyngeal cancer

  2022cites this paper
• Curative high‐dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure

  2022cites this paper
• Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges

  2022cites this paper
• Emerging Role of Carbon Ion Radiotherapy in Reirradiation of Recurrent Head and Neck Cancers: What Have We Achieved So Far?

  2022cites this paper
• Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

  2022cites this paper
• Clinical and technical challenges of cancer reirradiation: Words of wisdom.

  2022cites this paper
• Multicenter study of re‐irradiation using carbon‐ions for head and neck malignancies after photon radiotherapy

  2022cites this paper
• Exploring new proton emitting isotopes of Lanthanides

  2022cites this paper
• Treatment for Locoregionally Recurrent Head and Neck Cancers

  2022cites this paper
• Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence

  2022cites this paper
• Evaluation of the Response of HNSCC Cell Lines to γ-Rays and 12C Ions: Can Radioresistant Tumors Be Identified and Selected for 12C Ion Radiotherapy?

  2022cites this paper
• Proton re-irradiation of Sinonasal Esthesioneuroblastoma: a Case Report

  2021cites this paper
• Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.

  2021cites this paper
• Percutaneous Management of Recurrent Head and Neck Cancer: Current Role and Evolving Principles in the Multidisciplinary Setting

  2021cites this paper
• Radical external beam reirradiation of recurrent head and neck cancer.

  2021cites this paper
• Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives

  2021cites this paper
• Head and neck

  2021cites this paper
• Complications Related to Radical Neck Dissections and Management of Recurrent Neck Disease

  2021cites this paper
• Nasopharyngeal carcinoma: an evolving paradigm

  2021cites this paper
• Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects

  2021cites this paper
• Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single‐institution, modern cohort study

  2021cites this paper
• Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers

  2021cites this paper
• A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors

  2021cites this paper
• PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors

  2021cites this paper
• Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors

  2021cites this paper
• Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience

  2021cites this paper
• Proton Therapy for Head and Neck Cancer: Current Clinical Applications and Future Direction

  2021cites this paper
• Re-Irradiation for Local Relapses or Second Primaries: When and how?

  2021cites this paper
• Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review)

  2021cites this paper
• Proton therapy needs further technological development to fulfill the promise of becoming a superior treatment modality (compared to photon therapy)

  2021cites this paper
• Proton beam radiation therapy treatment for head and neck cancer

  2021cites this paper
• Reirradiation for Nasal Cavity or Paranasal Sinus Tumor—A Multi-Institutional Study

  2021cites this paper
• Proton theraPy sPecial feature: review article re- irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies

  2020cites this paper
• Particle therapy in the future of precision therapy.

  2020cites this paper
• Radical external beam re‐irradiation in the treatment of recurrent head and neck cancer: Critical review

  2020cites this paper
• Role of Proton Beam Therapy in Current Day Radiation Oncology Practice

  2020cites this paper
• Complex Clinical Decision-Making Process of Re-Irradiation.

  2020cites this paper
• Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomes

  2020cites this paper
• Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer

  2020cites this paper
• Proton Cancer Therapy: Synchrotron-Based Clinical Experiences 2020 Update

  2020cites this paper
• Proton re-irradiation of unresectable recurrent head and neck cancers

  2020cites this paper
• Past, present and future of proton therapy for head and neck cancer.

  2020cites this paper
• Proton/heavy ion therapy in salvage of locally recurrent nasopharyngeal carcinoma

  2020cites this paper
• Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes.

  2020cites this paper
• Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection

  2020cites this paper
• Prioritization of Proton Patients in the COVID-19 Pandemic: Recommendations from The New York Proton Center

  2020cites this paper
• Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies.

  2020cites this paper
• Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies

  2020cites this paper
• Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care.

  2020cites this paper
• The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer

  2020cites this paper
• Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.

  2020cites this paper
• Re-irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies.

  2020cites this paper
• Cancer of the Head and Neck

  2020cites this paper
• Therapeutic challenges in radiation-induced salivary gland cancers.

  2020cites this paper
• Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: A literature review.

  2019cites this paper
• New frontiers in proton therapy: applications in cancers

  2019cites this paper
• Patient Outcomes after Reirradiation of Small Skull Base Tumors using Stereotactic Body Radiotherapy, Intensity Modulated Radiotherapy, or Proton Therapy

  2019cites this paper
• Modern radiotherapy for head and neck cancer.

  2019cites this paper
• Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma

  2019cites this paper
• Palliative radiation therapy for head and neck cancers.

  2019cites this paper
• Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14).

  2019cites this paper
• Salvage Therapy for Local Progression following Definitive Therapy for Skull Base Chordomas: Is There a Role of Stereotactic Radiosurgery?

  2019cites this paper
• Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy.

  2019cites this paper
• Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma.

  2019cites this paper
• Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies

  2019cites this paper
• Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.

  2019cites this paper